Endothelial TLR2 promotes proangiogenic immune cell recruitment and tumor angiogenesis
- 19 January 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 14 (666)
Abstract
Toll-like receptor 2 contributes to innate immune responses in endothelial cells as well as in immune cells.Keywords
Funding Information
- National Institutes of Health (HL145536)
- National Institutes of Health (1S10RR026820-01)
This publication has 56 references indexed in Scilit:
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Critical Insights into Cardiovascular Disease from Basic Research on the Oxidation of Phospholipids: The γ-Hydroxyalkenal Phospholipid HypothesisChemical Research in Toxicology, 2011
- Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNKAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligandsNature, 2010
- Key Role of CD36 in Toll-Like Receptor 2 Signaling in Cerebral IschemiaStroke, 2010
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasisNature, 2009
- Vessel-Specific Toll-Like Receptor Profiles in Human Medium and Large ArteriesCirculation, 2008
- Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic eventsJournal of Experimental Medicine, 2008
- Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesisProceedings of the National Academy of Sciences, 2007
- Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesisProceedings of the National Academy of Sciences, 2006